The Necessity of Type and Screen Result Prior to Proceeding to Operating Room for Scheduled Cesarean Delivery in a Low Hemorrhage Risk Population - K23
Sunday, May 19, 2024
12:45 PM – 1:45 PM PDT
Location: Hall C
Sub Topic: Patient Safety and Quality Improvement
Authors:Brian Druyan MD; Michelle Fletcher BS; Michelande Ridore MS; Michael Paidas MD; Paloma Toledo ; Eva Hoffmann MD
University of Miami North Miami Beach, FL, United States
Disclosure(s):
Eva Hoffmann, MD: No financial relationships to disclose
Brian Z. Druyan, MD: No financial relationships to disclose
Michelle M. Fletcher, BS: No financial relationships to disclose
Michelande Ridore, MS: No financial relationships to disclose
Michael J. Paidas, MD: BioIncept, LLC: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing), University Grants/Research Support (Ongoing); Octapharma: Advisory Committee/Board Member (Ongoing); UpToDate: Royalties (Ongoing)
Paloma Toledo: Pacira Biosciences Inc: Speaker/Honoraria (Terminated, November 14, 2022)
